CN103145700A - 2-(2-benzyl hydrazono)-4-(benzofuran-5-yl) thiazole and preparation method and application thereof - Google Patents

2-(2-benzyl hydrazono)-4-(benzofuran-5-yl) thiazole and preparation method and application thereof Download PDF

Info

Publication number
CN103145700A
CN103145700A CN2013101097940A CN201310109794A CN103145700A CN 103145700 A CN103145700 A CN 103145700A CN 2013101097940 A CN2013101097940 A CN 2013101097940A CN 201310109794 A CN201310109794 A CN 201310109794A CN 103145700 A CN103145700 A CN 103145700A
Authority
CN
China
Prior art keywords
dimethyl
dihydrobenzofuranes
hydrazono
thiazole
methoxyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013101097940A
Other languages
Chinese (zh)
Other versions
CN103145700B (en
Inventor
胡艾希
魏莉
叶姣
沈芳
李婉
欧晓明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan University
Original Assignee
Hunan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan University filed Critical Hunan University
Priority to CN201310109794.0A priority Critical patent/CN103145700B/en
Publication of CN103145700A publication Critical patent/CN103145700A/en
Application granted granted Critical
Publication of CN103145700B publication Critical patent/CN103145700B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to 2-(2-benzyl hydrazono)-4-(benzofuran-5-yl) thiazole as shown in the chemical structural formula I and salt thereof, wherein R and R1 are selected from H, C1-C2 alkyl, C3-C4 straight chain alkyl or branch chain alkyl; X1-X5 are selected from hydrogen, C1-C2 alkyl, hydroxyl, methoxyl, ethoxyl, trifluoromethyl, fluorine, chlorine, bromine and nitryl; thiosemicarbazone is reacted with 2-holo-1-(7-methoxyl-2, 2-dimethyl-2, 3-dihydrobenzofuran-5-yl) alkyl ketone, and is neutralized to prepare 2-(2-benzyl hydrazono)-4-(2,2-dimethly-2, 3-dihydrobenzofuran-5-yl) thiazole. The compound is applied to preparing bactericide.

Description

2-(2-benzyl hydrazono-)-4-(cumarone-5-yl) thiazole and preparation method thereof and application
Technical field
The present invention relates to class new compound and its preparation method and application, specifically 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and preparation method thereof and as the application of sterilant.
Background technology
Benzofuranol (chemical name 2,2-dimethyl-2,3-Dihydrobenzofuranes phenol) is the important intermediate of producing carbofuran, pacifying well the large-tonnage carbamates chemicals for agriculture such as prestige and benfuracarb.Therefore the carbamate chemicals for agriculture activity is high, be widely used, but toxicity is larger, needs that exploitation toxicity is lower, activity substitute products preferably, with the demand of satisfying the market.As everyone knows, the exploitation of a new varieties of pesticides needed for 8~10 years, add that present new varieties of pesticides registration required data and project are many, required expense reaches multi-billion dollar, therefore world's novel pesticide initiative company transfers to part energy with existing intermediate and develops pesticide new variety, be intended to shorten the construction cycle, reduce development cost.The effect such as antiviral, antibiotic and desinsection that thiazole compound has.Chinese patent has been described non-carbamate chemicals for agriculture or other functional compounds based on the benzofuranol research and development, and following table is listed in the preparation and application of particular compound in:
Table is based on the application patent of benzofuranol
Figure 2013101097940100002DEST_PATH_IMAGE001
Summary of the invention
The object of the present invention is to provide the 2-shown in the chemical structural formula I (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and salt thereof.
Figure BDA0000299657212
Wherein, R is selected from: H, C 1~ C 2Alkyl, C 3~ C 4Straight chained alkyl or branched-chain alkyl; R 1Be selected from: H, C 1~ C 2Alkyl, C 3~ C 4Straight chained alkyl or branched-chain alkyl; X 1, X 5Be selected from: hydrogen, C 1~ C 2Alkyl, hydroxyl, methoxyl group, oxyethyl group, trifluoromethyl, fluorine, chlorine, bromine, nitro; X 2, X 4Be selected from: hydrogen, C 1~ C 2Alkyl, hydroxyl, methoxyl group, oxyethyl group, trifluoromethyl, fluorine, chlorine, bromine, nitro; X 3Be selected from: hydrogen, C 1~ C 2Alkyl, hydroxyl, methoxyl group, oxyethyl group, trifluoromethyl, fluorine, chlorine, bromine or nitro; Its salt is selected from hydrochloride, hydrobromate, nitrate, vitriol or phosphoric acid salt.
The object of the invention is to also provide 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) preparation method of thiazole, its preparation comprises the steps:
2-halogen-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) reaction of alkyl ketone and thiosemicarbazone makes 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole halogen acid salt (I .HX); 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole halogen acid salt obtains 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole through neutralization; Preparation is undertaken by following reaction formula:
Figure BDA0000299657213
.HX
Ⅰ.HX
Figure BDA0000299657214
Ⅰ.HX Ⅰ
In reaction formula, X is selected from: chlorine or bromine; R is selected from: H, C 1~ C 2Alkyl, C 3~ C 4Straight chained alkyl or branched-chain alkyl; R 1Be selected from: H, C 1~ C 2Alkyl, C 3~ C 4Straight chained alkyl or branched-chain alkyl; X 1, X 5Be selected from: hydrogen, C 1~ C 2Alkyl, hydroxyl, methoxyl group, oxyethyl group, trifluoromethyl, fluorine, chlorine, bromine, nitro; X 2, X 4Be selected from: hydrogen, C 1~ C 2Alkyl, hydroxyl, methoxyl group, oxyethyl group, trifluoromethyl, fluorine, chlorine, bromine, nitro; X 3Be selected from: hydrogen, C 1~ C 2Alkyl, hydroxyl, methoxyl group, oxyethyl group, trifluoromethyl, fluorine, chlorine, bromine or nitro; Its salt is selected from hydrochloride, hydrobromate, nitrate, vitriol or phosphoric acid salt.
the 2-that the object of the invention is to also provide (2-benzyl hydrazono-)-4-(2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or its salt are 2-[2-(2, 5-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(2, 3-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(3, 4-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole, 5-methyl-2-[2-(2, 3-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or 2-[2-(3, 4-benzyl dichloride hydrazono-)]-4-(7-oxyethyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or 2-[2-(2, 4-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure BDA0000299657215
the 2-that the object of the invention is to also provide (2-benzyl hydrazono-)-4-(2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or its salt are 2-[2-(2-benzyl chloride hydrazono-s)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or 2-[2-(3-benzyl chloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or 2-[2-(4-fluorine benzyl hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt, 2-[2-(4-benzyl chloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure BDA0000299657216
the 2-that the object of the invention is to also provide (2-benzyl hydrazono-)-4-(2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or its salt are 2-[2-(4-methoxybenzyl hydrazono-s)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or 2-[2-(4-methoxybenzyl hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or 2-[2-(4-methyl benzyl hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt, 2-[2-(2-methoxybenzyl hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure BDA0000299657217
Figure BDA0000299657218
the 2-that the object of the invention is to also provide (2-benzyl hydrazono-)-4-(2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or its salt are 5-methyl-2-[2-(4-nitrobenzyl hydrazono-s)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or 2-[2-(2-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt, 2-[2-(3-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt, 2-[2-(4-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure BDA0000299657219
The 2-that the object of the invention is to also provide (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) salt of thiazole is 2-[2-(2-hydroxyl-5-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt or 2-[2-(2-hydroxyl-4-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure BDA00002996572110
The 2-that the object of the invention is to also provide (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its salt are 2-[2-(2-hydroxyl benzyl hydrazono-s)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(4-hydroxyl benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its hydrobromate:
Figure BDA00002996572111
the 2-that the object of the invention is to also provide (2-benzyl hydrazono-)-4-(2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or its salt are 2-[2-(2-hydroxyl-3-chloro-5-bromobenzyl hydrazono-s)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or 2-[2-(2-hydroxyl-3, 5-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt, 2-[2-(2-hydroxyl-3, 5-cyclite hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt, 2-[2-(2-hydroxyl-3, 5-diiodo-benzyl hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure BDA00002996572112
The 2-that the object of the present invention is to provide (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its salt have good fungicidal activity, can use in the preparation sterilant.
The present invention compared with prior art has following advantage:
1. the present invention has prepared a class 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole first.
Figure BDA00002996572113
2. find first that 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and salt thereof have fungicidal activity, can be used for preparing sterilant.
Embodiment
Following examples are intended to illustrate the present invention rather than limitation of the invention further.
Embodiment 1
The preparation of 2-bromo-1-(7-oxyethyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone (C1)
C1
4.66 g 1-(7-oxyethyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 80 mL ethanol, stirring and refluxing adds 8.96 g cupric bromides, reaction 2 h, reacting liquor while hot is filtered, and revolves to steam to reclaim solvent, acetic acid ethyl dissolution, weak acid scrubbing filters, washing, separatory, drying, underpressure distillation gets crude product, and ethyl alcohol recrystallization gets white solid C1; Yield 72.0%, 98 ~ 100 ℃ of m.p..
Embodiment 2
The preparation of 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone (C2)
Figure BDA00002996572115
C2
4.38 g 1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 80 mL ethanol, stirring and refluxing adds 8.96 g cupric bromides, reaction 2 h, reacting liquor while hot is filtered, and revolves to steam to reclaim solvent, acetic acid ethyl dissolution, weak acid scrubbing filters, washing, separatory, drying, underpressure distillation gets crude product, and ethyl alcohol recrystallization gets white solid C2; Yield 50.0%, 90 ~ 91 ℃ of m.p..
Embodiment 3
The preparation of 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) acetone (C3)
Figure BDA00002996572116
C3
9.37 g 1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) acetone, 120 mL ethanol stirring and refluxing add 18.02 g(0.08 mol in batches) cupric bromide, react 2 h, reacting liquor while hot is filtered, and revolves the steaming solvent, acetic acid ethyl dissolution, weak acid scrubbing, filter, filtrate is through washing, separatory, underpressure distillation gets crude product, and ethyl alcohol recrystallization gets white solid C3; Yield 97.8%, 85 ~ 87 ℃ of m.p..
Embodiment 4
2-[2-(4-fluorine benzyl hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.62 g p-Fluorobenzenecarboxaldehyde, reaction 1 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(4-fluorine benzyl hydrazono-) thioamides; Yield 96.4%, 195 ~ 197 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.20 g2-(4-fluorine benzyl hydrazono-) thioamides, 15 mL ethanol reflux, the TLC monitoring reaction, react 0.2 h, the cooling solid of separating out of reaction solution filters, dry, ethyl alcohol recrystallization gets 2-[2-(4-fluorine benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 64.9%, 200 ~ 201 ℃ of m.p.. 1H NMR(CDCl 3,400 MHz) δ:1.54(s,6H,2×CH 3),3.09(s,2H,CH 2),3.98(s,3H,CH 3),6.57(s,1H,thiazole 5-H),7.12~7.17(m,4H,C 6H 2,C 6H 4 2,6-H),7.70(q,J = 8.8Hz,J = 5.2Hz,2H,C 6H 4 3,5-H),8.17(s,1H,N=CH)。
2-[2-(4-fluorine benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(4-fluorine benzyl hydrazono-) with ammonia neutralization]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 5
2-[2-(4-benzyl chloride hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.70 g 4-chloro-benzaldehyde, reaction 5.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(4-benzyl chloride hydrazono-) thioamides; Yield 87.9%, 209 ~ 211 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.21 g 2-(4-benzyl chloride hydrazono-) thioamides, 15 mL ethanol reflux, the TLC monitoring reaction, react 1.0 h, the cooling solid of separating out of reaction solution filters, dry, ethyl alcohol recrystallization gets 2-[2-(4-benzyl chloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 56.2%, 217 ~ 219 ℃ of m.p.. 1H NMR(CDCl 3,400 MHz) δ:1.55(s,6H,2×CH 3),3.09(s,2H,CH 2),3.99(s,3H,CH 3),6.56(s,1H,thiazole 5-H),7.14(s,2H,C 6H 2),7.43(d,J = 8.8Hz,2H,C 6H 4 2,6-H),7.65(d,J = 8.8Hz,2H,C 6H 4 3,5-H),8.23(s,1H,N=CH)。
2-[2-(4-benzyl chloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(4-benzyl chloride hydrazono-) with ammonia neutralization]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 6
2-[2-(2,4-benzyl dichloride hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
Figure BDA00002996572117
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.88 g 2,4 dichloro benzene formaldehyde, reaction 2.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(2,4-benzyl dichloride hydrazono-) thioamides; Yield 72.6%, 238 ~ 240 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.25 g 2-(2,4-benzyl dichloride hydrazono-) thioamides, 15 mL ethanol reflux, the TLC monitoring reaction, react 1.0 h, the cooling solid of separating out of reaction solution filters drying, ethyl alcohol recrystallization gets 2-[2-(2,4-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 73.7%, 227 ~ 228 ℃ of m.p.. 1H NMR(DMSO-d 6,400 MHz) δ:1.43(s,6H,2×CH 3),3.03(s,2H,CH 2),3.79(s,3H,CH 3),7.17(s,1H,thiazole 5-H),7.30(s,2H,C 6H 2),7.51(dd,J = 8.4Hz,J = 2.0Hz,1H,C 6H 3 5-H),7.69(d,J = 2.0Hz,1H,C 6H 3 3-H),7.91(d,J = 8.4Hz,1H,C 6H 3 6-H),8.32(s,1H,N=CH),12.45(brs,1H,NH)。
2-[2-(2,4-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(2 with ammonia neutralization, 4-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 7
2-[2-(4-methyl benzyl hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.60 g4-tolyl aldehyde, reaction 2.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(4-methyl benzyl hydrazono-) thioamides B4; Yield 80.8%, 166 ~ 168 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.19 g 2-(4-methyl benzyl hydrazono-) thioamides (B4), 15 mL ethanol reflux, the TLC monitoring reaction, react 0.3 h, the cooling solid of separating out of reaction solution filters, dry, ethyl alcohol recrystallization gets 2-[2-(4-methyl benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 67.4%, 221 ~ 223 ℃ of m.p.. 1H NMR(DMSO-d 6,400 MHz) δ:1.43(s,6H,2×CH 3),2.33(s,3H,CH 3),3.03(s,2H,CH 2),3.79(s,3H,CH 3),7.11(s,1H,thiazole 5-H),7.25(d,J = 8.0Hz,2H,C 6H 4 3,5-H),7.29(s,2H,C 6H 2),7.54(d,J = 8.0Hz,2H,C 6H 4 2,6-H),7.99(s,1H,N=CH),12.07(brs,1H,NH)。
2-[2-(4-methyl benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(4-methyl benzyl hydrazono-) with ammonia neutralization]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 8
2-[2-(2-methoxybenzyl hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.68 g Benzaldehyde,2-methoxy, reaction 4.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(2-methoxybenzyl hydrazono-) thioamides B5; Yield 84.2%, 215 ~ 216 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.21 g 2-(2-methoxybenzyl hydrazono-) thioamides (B5), 15 mL ethanol reflux, the TLC monitoring reaction, react 0.3 h, the cooling solid of separating out of reaction solution filters, dry, ethyl alcohol recrystallization gets 2-[2-(2-methoxybenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 73.5%, 224 ~ 226 ℃ of m.p.. 1H NMR(DMSO-d 6,400 MHz) δ:1.43(s,6H,2×CH 3),3.03(s,2H,CH 2),3.79(s,3H,CH 3),3.85(s,3H,CH 3),7.01(t,J = 7.2Hz,1H,C 6H 4 5-H),7.09(d,J = 8.0Hz,1H,C 6H 4 3-H),7.10(s,1H,thiazole 5-H),7.29(s,2H,C 6H 2),7.37(td,J = 7.2Hz,J = 1.6Hz,1H,C 6H 4 4-H),7.78(dd,J = 8.0Hz,J = 1.6Hz,1H,C 6H 4 6-H),8.34(s,1H,N=CH)。
2-[2-(2-methoxybenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt (obtain 2-[2-(2-methoxybenzyl hydrazono-) with ammonia neutralization]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 9
2-[2-(2-nitrobenzyl hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.76 g 2-nitrobenzaldehyde, reaction 5.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(2-nitrobenzyl hydrazono-) thioamides B6; Yield 96.4%, 246 ~ 247 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.22 g 2-(2-nitrobenzyl hydrazono-) thioamides (B6), 15 mL ethanol reflux, the TLC monitoring reaction, react 0.3 h, the cooling solid of separating out of reaction solution filters, dry, ethyl alcohol recrystallization gets 2-[2-(2-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 85.4%, 221 ~ 223 ℃ of m.p.. 1H NMR(DMSO-d 6,400 MHz) δ:1.43(s,6H,2×CH 3),3.04(s,2H,CH 2),3.79(s,3H,CH 3),7.19(s,1H,thiazole 5-H),7.30(s,2H,C 6H 2),7.61(t,J = 7.2Hz,1H,C 6H 4 5-H),7.79(t,J = 7.6Hz,1H,C 6H 4 4-H),8.04(d,J = 8.0Hz,2H,C 6H 4 3,6-H),8.41(s,1H,N=CH),12.54(brs,1H,NH)。
2-[2-(2-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(2-nitrobenzyl hydrazono-) with ammonia neutralization]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 10
2-[2-(3-nitrobenzyl hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.76 g3-nitrobenzaldehyde, reaction 2.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(3-nitrobenzyl hydrazono-) thioamides B7; Yield 89.3%, 231 ~ 232 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.22 g 2-(3-nitrobenzyl hydrazono-) thioamides (B7), 15 mL ethanol reflux, the TLC monitoring reaction, react 0.3 h, the cooling solid of separating out of reaction solution filters, dry, ethyl alcohol recrystallization gets 2-[2-(3-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 83.3%, 238 ~ 240 ℃ of m.p.. 1H NMR(DMSO-d 6,400 MHz) δ:1.43(s,6H,2×CH 3),3.04(s,2H,CH 2),3.80(s,3H,CH 3),7.18(s,1H,thiazole 5-H),7.31(s,2H,C 6H 2),7.73(t,J = 8.0Hz,1H,C 6H 4 5-H),8.09(d,J = 8.0Hz,1H,C 6H 4 6-H),8.14(s,1H,C 6H 4 2-H),8.20(dd,J = 8.4Hz,J = 1.6Hz,1H,C 6H 4 4-H),8.47(s,1H,N=CH),12.47(brs,1H,NH)。
2-[2-(3-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(3-nitrobenzyl hydrazono-) with ammonia neutralization]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 11
2-[2-(4-nitrobenzyl hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.76 g4-nitrobenzaldehyde, reaction 4.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(4-nitrobenzyl hydrazono-) thioamides B8; Yield 98.2%, 238 ~ 239 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.22 g 2-(4-nitrobenzyl hydrazono-) thioamides (B8), 15 mL ethanol reflux, the TLC monitoring reaction, react 0.2 h, the cooling solid of separating out of reaction solution filters, dry, ethyl alcohol recrystallization gets 2-[2-(4-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 85.4%, 223 ~ 225 ℃ of m.p.. 1H NMR(CDCl 3,400 MHz) δ:1.55(s,6H,2×CH 3),3.10(s,2H,CH 2),3.99(s,3H,CH 3),6.63(s,1H,thiazole 5-H), 7.15(s,2H,C 6H 2),7.88(d,J = 8.8Hz,2H,C 6H 4 2,6-H),8.31(d,J = 8.8Hz,2H,C 6H 4 3,5-H),8.31(s,1H,N=CH)。
2-[2-(4-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(4-nitrobenzyl hydrazono-) with ammonia neutralization]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 12
2-[2-(2-hydroxyl-5-nitrobenzyl hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.84 g 2-hydroxyl-5-nitrobenzaldehyde, reaction 2.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(2-hydroxyl-5-nitrobenzyl hydrazono-) thioamides B9; Yield 95.8%, 243 ~ 244 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.24 g 2-(2-hydroxyl-5-nitrobenzyl hydrazono-) thioamides (B9), 15 mL ethanol reflux, the TLC monitoring reaction, react 1.0 h, the cooling solid of separating out of reaction solution filters, dry, ethyl alcohol recrystallization gets 2-[2-(2-hydroxyl-5-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 84.1%, 237 ~ 238 ℃ of m.p.. 1H NMR(CDCl 3,400 MHz) δ:1.55(s,6H,2×CH 3),3.10(s,2H,CH 2),3.99(s,3H,CH 3),6.64(s,1H,thiazole 5-H),7.13~7.17(m,3H,C 6H 2,C 6H 3 3-H),8.28~8.33(m,2H,C 6H 3 4,6-H),8.57(s,1H,N=CH),10.09(s,1H,OH),13.68(brs,1H,NH),14.05(brs,1H,HBr)。
2-[2-(2-hydroxyl-5-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(2-hydroxyl-5-nitrobenzyl hydrazono-) with ammonia neutralization]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 13
2-[2-(2-hydroxyl benzyl hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.61 g Benzaldehyde,2-hydroxy, reaction 4.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(2-hydroxyl benzyl hydrazono-) thioamides B10; Yield 94.4%, 222 ~ 224 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.20 g 2-(2-hydroxyl benzyl hydrazono-) thioamides (B10), 15 mL ethanol reflux, the TLC monitoring reaction, react 0.2 h, the cooling solid of separating out of reaction solution filters, dry, ethyl alcohol recrystallization gets 2-[2-(2-hydroxyl benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 54.1%, 203 ~ 205 ℃ of m.p.. 1H NMR(DMSO-d 6,400 MHz) δ:1.43(s,6H,2×CH 3),3.03(s,2H,CH 2),3.79(s,3H,CH 3),6.88(t,J = 7.2Hz,1H,C 6H 4 5-H),6.90(d,J = 8.4Hz,1H,C 6H 4 3-H),7.11(s,1H,thiazole 5-H),7.22(td,J = 8.4Hz,J = 1.6Hz,1H,C 6H 4 4-H),7.29(s,2H,C 6H 2),7.61(d,J = 7.2Hz,1H,C 6H 4 6-H),8.30(s,1H,N=CH),10.09(brs,1H,OH),12.11(brs,1H,NH)。
2-[2-(2-hydroxyl benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(2-hydroxyl benzyl hydrazono-) with ammonia neutralization]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 14
2-[2-(4-hydroxyl benzyl hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip the ethanolic soln of 0.61 g4-hydroxy benzaldehyde, reaction 2.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(4-hydroxyl benzyl hydrazono-) thioamides B11; Yield 89.2%, 225 ~ 227 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.20 g 2-(4-hydroxyl benzyl hydrazono-) thioamides (B11), 15 mL ethanol reflux, the TLC monitoring reaction, react 0.3 h, the cooling solid of separating out of reaction solution filters, dry, ethyl alcohol recrystallization gets 2-[2-(4-hydroxyl benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 52.0%, 233 ~ 234 ℃ of m.p.. 1H NMR(DMSO-d 6,400 MHz) δ:1.42(s,6H,2×CH 3),3.03(s,2H,CH 2),3.79(s,3H,CH 3),6.82(d,J = 8.8Hz,2H,C 6H 4 3,5-H),7.08(s,1H,thiazole 5-H),7.28,7.29(2×s,2H,C 6H 2),7.48(d,J = 8.8Hz,2H,C 6H 4 2,6-H),7.93(s,1H,N=CH),9.86(brs,1H,OH),11.94(brs,1H,NH)。
2-[2-(4-hydroxyl benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(4-hydroxyl benzyl hydrazono-) with ammonia neutralization]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 15
2-[2-(2-hydroxyl-3,5-benzyl dichloride hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip 0.96 g 2-hydroxyl-3, the ethanolic soln of 5-dichlorobenzaldehyde, reaction 5.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(2-hydroxyl-3,5-benzyl dichloride hydrazono-) thioamides B12; Yield 68.2%, 242 ~ 244 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.26 g 2-(2-hydroxyl-3,5-benzyl dichloride hydrazono-) thioamides (B12), 15 mL ethanol, reflux, the TLC monitoring reaction, react 0.3 h, the cooling solid of separating out of reaction solution filters drying, ethyl alcohol recrystallization gets 2-[2-(2-hydroxyl-3,5-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 80.7%, 257 ~ 259 ℃ of m.p.. 1H NMR(CDCl 3,400 MHz) δ:1.55(s,6H,2×CH 3),3.10(s,2H,CH 2),3.99(s,3H,CH 3),6.62(s,1H,thiazole 5-H),7.13,7.14(2×s,2H,C 6H 2),7.31(d,J = 2.4Hz,1H,C 6H 2 6-H),7.49(d,J = 2.4Hz,1H,C 6H 2 4-H),8.46(s,1H,N=CH),9.48(s,1H,OH)。
2-[2-(2-hydroxyl-3,5-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(2-hydroxyl-3 with ammonia neutralization, 5-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 16
2-[2-(2-hydroxyl-3,5-cyclite hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.46 g thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip 1.40 g 2-hydroxyls-3, the ethanolic soln of 5-dibromo benzaldehyde, reaction 2.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(2-hydroxyl-3,5-cyclite hydrazono-) thioamides B13; Yield 90.1%, 237 ~ 238 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.35 g 2-(2-hydroxyl-3,5-cyclite hydrazono-) thioamides (B13), 15 mL ethanol, reflux, the TLC monitoring reaction, react 0.2 h, the cooling solid of separating out of reaction solution filters drying, ethyl alcohol recrystallization gets 2-[2-(2-hydroxyl-3,5-cyclite hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 83.4%, 263 ~ 265 ℃ of m.p.. 1H NMR(CDCl 3,400 MHz) δ:1.55(s,6H,2×CH 3),3.10(s,2H,CH 2),3.98(s,3H,CH 3),6.63(s,1H,thiazole 5-H),7.12,7.14(2×s,2H,C 6H 2),7.47(d,J = 2.0Hz,1H,C 6H 2 6-H),7.78(d,J = 2.0Hz,1H,C 6H 2 4-H),8.41(s,1H,N=CH),9.66(s,1H,OH)。
2-[2-(2-hydroxyl-3,5-cyclite hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(2-hydroxyl-3 with ammonia neutralization, 5-cyclite hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 17
2-[2-(2-hydroxyl-3,5-diiodo-benzyl hydrazono-)]-preparation of 4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and hydrobromate thereof
0.18 g(2 mmol) thiosemicarbazide, 20 mL alcohol-waters (1: 3) reflux, and slowly drip 0.75 g(2 mmol) 2-hydroxyl-3, the ethanolic soln of 5-diiodo-benzene formaldehyde, reaction 2.0 h.The cooling solid of separating out of reaction solution filters, drying, and ethyl alcohol recrystallization gets 2-(2-hydroxyl-3,5-diiodo-benzyl hydrazono-) thioamides B14; Yield 81.7%, 210 ~ 211 ℃ of m.p..
0.30 g 2-bromo-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) ethyl ketone, 0.45 g 2-(2-hydroxyl-3,5-diiodo-benzyl hydrazono-) thioamides (B14), 15 mL ethanol, reflux, the TLC monitoring reaction, react 1.0 h, the cooling solid of separating out of reaction solution filters drying, ethyl alcohol recrystallization gets 2-[2-(2-hydroxyl-3,5-diiodo-benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt; Yield 79.3%, 237 ~ 239 ℃ of m.p.. 1H NMR(CDCl 3,400 MHz) δ:1.55(s,6H,2×CH 3),3.10(s,2H,CH 2),3.98(s,3H,CH 3),6.62(s,1H,thiazole 5-H),7.11,7.13(2×s,2H,C 6H 2),7.61(d,J = 2.0Hz,1H,C 6H 2 6-H),8.13(d,J = 2.0Hz,1H,C 6H 2 4-H),8.33(s,1H,N=CH),10.08(s,1H,OH)。
2-[2-(2-hydroxyl-3,5-diiodo-benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt obtains 2-[2-(2-hydroxyl-3 with ammonia neutralization, 5-diiodo-benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole.
Embodiment 18
The fungicidal activity of 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole is measured
1 test objective
At indoor measurement new compound under for examination concentration to the virulence of various pathogenic bacterias, its fungicidal activity of preliminary assessment.
2 test conditionss
2.1 for the examination target
Sclerotinia sclerotiorum (Sclerotonia sclerotiorum); Bacterial classification all is kept in refrigerator (4-8 ℃), is inoculated in culture dish from the test tube slant in 2-3 days before test, cultivates to be for experiment under optimal temperature.Experiment is potato agar substratum (PDA) with substratum.
Wheat powdery mildew (Blumeria graminis) is preserved spore with stem and leaf of Wheat and is for experiment.
2.2 culture condition
Culture condition for target after examination target and test is 25 ± 5 ℃ of temperature, relative humidity 65 ± 5%
2.3 plant and instrument
Beaker, transfer pipet, graduated cylinder, culture dish, high-pressure sterilizing pot, constant temperature biochemical cultivation case etc.
3 test design
3.1 test medicine
2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and salt thereof.
3.2 experimental concentration
Stripped drug concentration is established 25mg/L, and Broad Bean Leaves method drug concentration is established 500mg/L.
3.3 medicament preparation
Former medicine: take aequum with ten thousand/electronic balance; Solvent: DMF (DMF), 0.2%; Emulsifying agent: Tween 80,0.1%;
General sieve is measured: accurately take the 0.0500g sample, with the 0.20mLDMF dissolving, add the sterilized water 98.8ml that contains 0.1% Tween80 emulsifying agent, stir, be mixed with 500mg/L concentration solution for standby.
4 test methods
With reference to " pesticide bioactivity is estimated SOP ".
Sclerotinia sclerotiorum: with reference to giving birth to the accurate method NY/T1156.2-2006 of mark, adopt the pastille medium therapy: get each 500mg/L compound liquid 2mL, add in the PDA of the 38mL that is cooled to 45 ℃, making final concentration is the pastille culture medium flat plate of 25mg/L.Then get 6.5mm diameter mycelia piece from cultured test germ colony edge, move on the pastille substratum, every processing repeats for 4 times.Be disposed, the constant temperature biochemical cultivation case that is placed in 28 ℃ is cultivated, and measures colony diameter after 4 days, calculates growth inhibition ratio.
Wheat powdery mildew: adopt pot-culture method with reference to giving birth to the accurate method NY/T1156.4-2006 of mark; select seedling to grow to the susceptible variety stem and leaf of Wheat of 2 leaves ~ 3 leaf phases; with spray method with 500mg/L compound medicine liquid spray on stem and leaf of Wheat; naturally dry; the fresh spore of Powdery Mildew that the morbidity wheat leaf blade produced in upper 24 hour is evenly shaken off to be inoculated on stem and leaf of Wheat, and every processing is no less than 3 basins, every basin 10 strains; the protectiveness test is inoculation in 24 hours after chemicals treatment, then puts under suitable condition and cultivates.According to blank incidence classification investigation, calculate prevention effect.
5 fungicidal activity evaluations
After processing, routine observation records incidence and the mycelial growth situation of blade, plant, according to disease index and hyphal diameter, calculates preventive effect and inhibiting rate.
Figure BDA00002996572118
In formula: P represents prevention effect, D 0Expression blank scab diameter, D 1The scab diameter is processed in expression
2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) the general sieve result of thiazole fungicidal activity is: outstanding compound 2-[2-(2,4-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) inhibiting rate of thiazole hydrobromide salt pair Sclerotinia sclerotiorum (25 mg/L) and wheat powdery mildew (500mg/L) is respectively 72.5% and 80.0%.
The demonstration of active testing result, 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and salt thereof have good fungicidal activity, can be used for preparing sterilant.

Claims (10)

1. the 2-shown in the chemical structural formula I (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its salt:
Figure FDA0000299657201
Wherein, R is selected from: H, C 1~ C 2Alkyl, C 3~ C 4Straight chained alkyl or branched-chain alkyl; R 1Be selected from: H, C 1~ C 2Alkyl, C 3~ C 4Straight chained alkyl or branched-chain alkyl; X 1, X 5Be selected from: hydrogen, C 1~ C 2Alkyl, hydroxyl, methoxyl group, oxyethyl group, trifluoromethyl, fluorine, chlorine, bromine, nitro; X 2, X 4Be selected from: hydrogen, C 1~ C 2Alkyl, hydroxyl, methoxyl group, oxyethyl group, trifluoromethyl, fluorine, chlorine, bromine, nitro; X 3Be selected from: hydrogen, C 1~ C 2Alkyl, hydroxyl, methoxyl group, oxyethyl group, trifluoromethyl, fluorine, chlorine, bromine or nitro; Its salt is selected from hydrochloride, hydrobromate, nitrate, vitriol or phosphoric acid salt.
2. the described 2-of claim 1 (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its salt, described compound is 2-[2-(2, 5-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(2, 3-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(3, 4-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole, 5-methyl-2-[2-(2, 3-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(3, 4-benzyl dichloride hydrazono-)]-4-(7-oxyethyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole or 2-[2-(2, 4-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure FDA0000299657202
3. the described 2-of claim 1 (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its salt; described compound is 2-[2-(2-benzyl chloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(3-benzyl chloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(4-fluorine benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt or 2-[2-(4-benzyl chloride hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure FDA0000299657203
4. the described 2-of claim 1 (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its salt; described compound is 2-[2-(4-methoxybenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(4-methoxybenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(4-methyl benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt or 2-[2-(2-methoxybenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure FDA0000299657204
5. the described 2-of claim 1 (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its salt; described compound is 5-methyl-2-[2-(4-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(2-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt, 2-[2-(3-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt or 2-[2-(4-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure FDA0000299657205
6. the described 2-of claim 1 (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) salt of thiazole is 2-[2-(2-hydroxyl-5-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt or 2-[2-(2-hydroxyl-4-nitrobenzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure FDA0000299657206
7. the described 2-of claim 1 (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its salt; Described compound is 2-[2-(2-hydroxyl benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(4-hydroxyl benzyl hydrazono-)]-4-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its hydrobromate:
Figure FDA0000299657207
8. the described 2-of claim 1 (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its salt, described compound is 2-[2-(2-hydroxyl-3-chloro-5-bromobenzyl hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole, 2-[2-(2-hydroxyl-3, 5-benzyl dichloride hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt, 2-[2-(2-hydroxyl-3, 5-cyclite hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt or 2-[2-(2-hydroxyl-3, 5-diiodo-benzyl hydrazono-)]-4-(7-methoxyl group-2, 2-dimethyl-2, 3-Dihydrobenzofuranes-5-yl) thiazole hydrobromide salt:
Figure FDA0000299657208
9. the preparation method of the described 2-of any one (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole and salt thereof in claim 1 ~ 8; The preparation that it is characterized in that it comprises the steps:
2-halogen-1-(7-methoxyl group-2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) reaction of alkyl ketone and thiosemicarbazone makes 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole halogen acid salt (I .HX); 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole halogen acid salt obtains 2-(2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole (I) through neutralization; Preparation is undertaken by following reaction formula:
Figure FDA0000299657209
R, R in formula 1, X 1~ X 5Definition as claimed in claim 1; X is selected from: Cl or Br.
10. the described 2-of any one (2-benzyl hydrazono-)-4-(2,2-dimethyl-2,3-Dihydrobenzofuranes-5-yl) thiazole or its salt application in the preparation sterilant in claim 1,2 or 3 ~ 8.
CN201310109794.0A 2013-04-01 2013-04-01 2-(2-benzyl hydrazono)-4-(benzofuran-5-yl) thiazole and preparation method and application thereof Expired - Fee Related CN103145700B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310109794.0A CN103145700B (en) 2013-04-01 2013-04-01 2-(2-benzyl hydrazono)-4-(benzofuran-5-yl) thiazole and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310109794.0A CN103145700B (en) 2013-04-01 2013-04-01 2-(2-benzyl hydrazono)-4-(benzofuran-5-yl) thiazole and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN103145700A true CN103145700A (en) 2013-06-12
CN103145700B CN103145700B (en) 2015-04-01

Family

ID=48544077

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310109794.0A Expired - Fee Related CN103145700B (en) 2013-04-01 2013-04-01 2-(2-benzyl hydrazono)-4-(benzofuran-5-yl) thiazole and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN103145700B (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103342703A (en) * 2013-07-22 2013-10-09 湖南大学 N-[4-(benzofuran-5-yl)thiazole-2-yl] amide as well as preparation method and application for same
CN104026137A (en) * 2014-06-19 2014-09-10 湖南海利株洲精细化工有限公司 Application of N-[4-(benzofuran-5-radical) thiazole-2-radical] fatty acid amide as insecticide
CN104387373A (en) * 2014-10-27 2015-03-04 湖南大学 1-(7-propoxy benzofuran-5-group)-3-(2-methoxyl phenyl)-2-(1,2,4-triazole-1- group)acrylketone
CN104642314A (en) * 2015-02-04 2015-05-27 宁波工程学院 Application of N-furan phenol methyl ether-5-yl) chromene-4-amide as sterilizing agent
CN104774199A (en) * 2014-01-09 2015-07-15 湖南大学 2-(2-benzylidene hydrazino)-5-(1,2,4-triazole-1-yl)thiazole, and preparation and applications thereof
CN105585563A (en) * 2014-10-24 2016-05-18 湖南大学 1-(benzofuran-5-yl)-3-phenyl-2-(1,2,4-triazol-1-yl)propenol and application thereof
CN105585562A (en) * 2014-10-24 2016-05-18 湖南大学 1-(benzofuran-5-yl)-3-aryl-2-(triazol-1-yl)-propenone and application thereof as anticancer drug
CN105985332A (en) * 2015-02-10 2016-10-05 湖南大学 2-[5-(triazolyl-1-yl)thiazolyl-2-imino]-5-benzalthiazolinone and its preparation method and use
CN111978306A (en) * 2019-05-24 2020-11-24 湖南大学 Furanol pyrazole formamide derivative and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07149747A (en) * 1993-11-30 1995-06-13 Hodogaya Chem Co Ltd Thiazole derivative
WO2010151799A2 (en) * 2009-06-26 2010-12-29 University Of Massachusetts Compounds for modulating rna binding proteins and uses therefor
CN102010406A (en) * 2010-11-23 2011-04-13 湖南大学 4-(benzofuran-5-yl)-2-aromatic aminothiazole and preparation method and application thereof
CN102177897A (en) * 2011-04-25 2011-09-14 湖南大学 Application of 5-(2-(benzyl imino group) thiazole-4-group) furan phenol ether in preparing bactericide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07149747A (en) * 1993-11-30 1995-06-13 Hodogaya Chem Co Ltd Thiazole derivative
WO2010151799A2 (en) * 2009-06-26 2010-12-29 University Of Massachusetts Compounds for modulating rna binding proteins and uses therefor
CN102010406A (en) * 2010-11-23 2011-04-13 湖南大学 4-(benzofuran-5-yl)-2-aromatic aminothiazole and preparation method and application thereof
CN102177897A (en) * 2011-04-25 2011-09-14 湖南大学 Application of 5-(2-(benzyl imino group) thiazole-4-group) furan phenol ether in preparing bactericide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
沈芳,等: "4-(7-甲氧基-2,2-二甲基-2,3-二氢苯并呋喃-5-基)-2-苄亚氨基噻唑的合成与生物活性", 《有机化学》 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103342703A (en) * 2013-07-22 2013-10-09 湖南大学 N-[4-(benzofuran-5-yl)thiazole-2-yl] amide as well as preparation method and application for same
CN103342703B (en) * 2013-07-22 2015-07-29 湖南大学 N-[4-(cumarone-5-base) thiazol-2-yl] acid amides and preparation method thereof and application
CN104774199B (en) * 2014-01-09 2017-03-08 湖南大学 2‑(2 benzyl hydrazono-s)‑5‑(1,2,4 triazole, 1 base)Thiazole and its preparation and application
CN104774199A (en) * 2014-01-09 2015-07-15 湖南大学 2-(2-benzylidene hydrazino)-5-(1,2,4-triazole-1-yl)thiazole, and preparation and applications thereof
CN104026137A (en) * 2014-06-19 2014-09-10 湖南海利株洲精细化工有限公司 Application of N-[4-(benzofuran-5-radical) thiazole-2-radical] fatty acid amide as insecticide
CN105585562A (en) * 2014-10-24 2016-05-18 湖南大学 1-(benzofuran-5-yl)-3-aryl-2-(triazol-1-yl)-propenone and application thereof as anticancer drug
CN105585563A (en) * 2014-10-24 2016-05-18 湖南大学 1-(benzofuran-5-yl)-3-phenyl-2-(1,2,4-triazol-1-yl)propenol and application thereof
CN104387373B (en) * 2014-10-27 2017-02-15 湖南大学 1-(7-propoxy benzofuran-5-group)-3-(2-methoxyl phenyl)-2-(1,2,4-triazole-1- group)acrylketone
CN104387373A (en) * 2014-10-27 2015-03-04 湖南大学 1-(7-propoxy benzofuran-5-group)-3-(2-methoxyl phenyl)-2-(1,2,4-triazole-1- group)acrylketone
CN104642314A (en) * 2015-02-04 2015-05-27 宁波工程学院 Application of N-furan phenol methyl ether-5-yl) chromene-4-amide as sterilizing agent
CN104642314B (en) * 2015-02-04 2017-05-17 宁波工程学院 Application of N-furan phenol methyl ether-5-yl) chromene-4-amide as sterilizing agent
CN105985332A (en) * 2015-02-10 2016-10-05 湖南大学 2-[5-(triazolyl-1-yl)thiazolyl-2-imino]-5-benzalthiazolinone and its preparation method and use
CN105985332B (en) * 2015-02-10 2018-09-21 湖南大学 2- [5- (nitrogen azoles -1- bases) thiazole -2- imino groups] -5- benzal thiazolinones and the preparation method and application thereof
CN111978306A (en) * 2019-05-24 2020-11-24 湖南大学 Furanol pyrazole formamide derivative and preparation method and application thereof
CN111978306B (en) * 2019-05-24 2023-01-03 湖南大学 Furanol pyrazole formamide derivative and preparation method and application thereof

Also Published As

Publication number Publication date
CN103145700B (en) 2015-04-01

Similar Documents

Publication Publication Date Title
CN103145700B (en) 2-(2-benzyl hydrazono)-4-(benzofuran-5-yl) thiazole and preparation method and application thereof
CN101602761B (en) 4-tert-butyl-5-(1,2,4-triazol-1-yl)-2-benzylimino thiazole and preparation method and application thereof
CN102177897B (en) Application of 5-(2-(benzyl imino group) thiazole-4-group) furan phenol ether in preparing bactericide
CN103664808B (en) A kind of aryl 3-triazole compounds containing chlorocyclopropane and preparation method thereof and application
CN102675303B (en) 4-alkyl-2-arylamino-5-(1,2,4-triazole-1-group) thiazole and application thereof to preparation of medicaments for resisting cancer
CN105949181A (en) 4-hydroxyl pyrroline-2-ketone derivative containing 1,3,4-oxadiazole and preparation method and application of 4-hydroxyl pyrroline-2-ketone derivative
CN104592216A (en) 5-phenyl-1,3,4-oxadiazole derivative as well preparation method and application thereof
CN104530035A (en) 5-piperonyl-4-alkyl-2-aromatic aminothiazole and preparing method and application thereof
CN103524417B (en) One group of 3-methyl-4-formyl pyrazole compound
CN101337945B (en) 4-acetamino-3-(4-arylthiazole-2-amino)benzoate, method for preparing same and applications
CN102993105B (en) 1-methyl-2, 4-quinazoline diketone derivative and preparation method and application thereof
CN103535358B (en) Bactericide usage of group of ortho substituted benzoyl compounds
CN103141486B (en) Application of 4-(benzofuran-5-yl)-2-phenzyl aminothiazole as bactericide
CN103342703B (en) N-[4-(cumarone-5-base) thiazol-2-yl] acid amides and preparation method thereof and application
CN103275073B (en) 2-(1,2,4-triazole-1-methyl)-2-(cumarone-5-base)-DOX and application thereof
CN103524418A (en) 3-methyl pyrazol compounds
CN104003924B (en) N-replaces-3-[3-(substituted-phenyl)-2-alkene-1-ketone]-4-hydroxypyrrole quinoline-2-ketone compounds and preparation method and application
CN103524407B (en) One group of 2-fluoro-3-pyridine carbamoyl compound
CN103304553B (en) 2-(propylene-2-yl)-2,3-dihydro-4-benzofuranol as well as preparation method and application thereof
CN104910094A (en) 1-amido-2-aryl-2,4-dihydro-3,1-benzoxazine compounds with bactericidal activity and application thereof
CN101584338B (en) N-nitryl-N-phenyl-N'-pyridylurea derivatives with sterilizing activity and preparing method thereof
CN105111221B (en) Furans and the 9 oxime derivate of chroman 6 and preparation method and application
CN104557888A (en) Application of furan phenol allyl alcohol derivative used as herbicide
CN105153177B (en) Furans and chroman oxime alkene/propargyl ether and preparation method and application
CN103554026A (en) 3-trifluoromethyl-4-formyl pyrazole compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150401

Termination date: 20180401

CF01 Termination of patent right due to non-payment of annual fee